{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:36:35Z","timestamp":1789616195472,"version":"build-2803163510"},"reference-count":243,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.drup.2026.101437","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:30:15Z","timestamp":1781911815000},"page":"101437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Autophagy in thyroid cancer: Immune suppression and drug resistance"],"prefix":"10.1016","volume":"88","author":[{"given":"Huan","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bicheng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3754-5712","authenticated-orcid":false,"given":"Alan Prem","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0658-4604","authenticated-orcid":false,"given":"Prakash","family":"Gangadaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3823-6572","authenticated-orcid":false,"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1976-9405","authenticated-orcid":false,"given":"Jia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingda","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2026.101437_bib1","doi-asserted-by":"crossref","unstructured":"Ahn, S., Kim, T.H., Kim, S.W., Ki, C.S., Jang, H.W., 2017. Comprehensive screening for PD-L1 expression in thyroid cancer. https:\/\/doi.org\/10.1530\/ERC-16-0421.","DOI":"10.1530\/ERC-16-0421"},{"key":"10.1016\/j.drup.2026.101437_bib2","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1101\/gad.287524.116","article-title":"Recent insights into the function of autophagy in cancer","volume":"30","author":"Amaravadi","year":"2016","journal-title":"Genes. Dev."},{"key":"10.1016\/j.drup.2026.101437_bib3","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1158\/1078-0432.CCR-13-0095","article-title":"Phase I trial of a new schedule of romidepsin in patients with advanced cancers","volume":"19","author":"Amiri-Kordestani","year":"2013","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2026.101437_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.prp.2011.05.002","article-title":"Mutational and expressional analyses of ATG5, an autophagy-related gene, in gastrointestinal cancers","volume":"207","author":"An","year":"2011","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.drup.2026.101437_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10549-019-05381-y","article-title":"A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients","volume":"178","author":"Arnaout","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.drup.2026.101437_bib6","doi-asserted-by":"crossref","unstructured":"Arora, S.P., Tenner, L.L., Sarantopoulos, J., Morris, J.L., Longoria, L., Liu, Q., Michalek, J., Mahalingam, D., 2019. Modulation of autophagy: A phase II study of vorinostat (VOR) plus hydroxychloroquine (HCQ) vs regorafenib (RGF) in chemo-refractory metastatic colorectal cancer (mCRC).","DOI":"10.1200\/JCO.2019.37.15_suppl.3551"},{"key":"10.1016\/j.drup.2026.101437_bib7","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.1304790110","article-title":"Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia","volume":"110","author":"Baginska","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.drup.2026.101437_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111743","article-title":"Unravelling the epigenetic based mechanism in discovery of anticancer phytomedicine: Evidence based studies","volume":"131","author":"Bashir","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.drup.2026.101437_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105390","article-title":"The cholesterol-derived metabolite dendrogenin A functionally reprograms breast adenocarcinoma and undifferentiated thyroid cancer cells","volume":"192","author":"Bauriaud-Mallet","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.drup.2026.101437_bib10","series-title":"in: Annales Pharmaceutiques Fran\u00e7aises","article-title":"Formulation of repurposed celecoxib-loaded nanostructured lipid carriers using Box-Behnken design, its characterization, and anticancer evaluation","author":"Bhavar","year":"2025"},{"key":"10.1016\/j.drup.2026.101437_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-018-0804-2","article-title":"Kinase-targeted cancer therapies: progress, challenges and future directions","volume":"17","author":"Bhullar","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101437_bib12","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/0303-7207(91)90018-N","article-title":"Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation","volume":"82","author":"Brabant","year":"1991","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.drup.2026.101437_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/icb.2014.81","article-title":"Autophagy in T-cell development, activation and differentiation","volume":"93","author":"Bronietzki","year":"2015","journal-title":"Immunol. Cell. Biol."},{"key":"10.1016\/j.drup.2026.101437_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","article-title":"Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial","volume":"384","author":"Brose","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2026.101437_bib15","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1586\/era.12.96","article-title":"Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma","volume":"12","author":"Brose","year":"2012","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.drup.2026.101437_bib16","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-11-3396","article-title":"Cell-mediated autophagy promotes cancer cell survival","volume":"72","author":"Buchser","year":"2012","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.drup.2026.101437_bib17","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1530\/ERC-19-0491","article-title":"Redifferentiation of radioiodine-refractory thyroid cancers","volume":"27","author":"Buffet","year":"2020","journal-title":"Endocr. -Relat. Cancer"},{"key":"10.1016\/j.drup.2026.101437_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tox.2008.07.048","article-title":"Cell death and autophagy: Cytokines, drugs, and nutritional factors","volume":"254","author":"Bursch","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.drup.2026.101437_bib19","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1210\/jc.2009-1923","article-title":"Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the MD Anderson experience","volume":"95","author":"Cabanillas","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drup.2026.101437_bib20","first-page":"3831","article-title":"Prognostic value of autophagy related proteins ULK1, Beclin1, ATG3, ATG5, ATG7, ATG9, ATG10, ATG12, LC3B and p62\/SQSTM1 in gastric cancer","volume":"8","author":"Cao","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.drup.2026.101437_bib21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3892\/ol.2021.12814","article-title":"PD-L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: A retrospective study","volume":"22","author":"Cameselle-Garcia","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.drup.2026.101437_bib22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1590\/S0004-27302007000500004","article-title":"The importance of sodium\/iodide symporter (NIS) for thyroid cancer management","volume":"51","author":"Carvalho","year":"2007","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.drup.2026.101437_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1593\/neo.08916","article-title":"RET\/PTC1-driven neoplastic transformation and proinvasive phenotype of human thyrocytes involve Met induction and \u03b2-catenin nuclear translocation","volume":"11","author":"Cassinelli","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.drup.2026.101437_bib24","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1158\/0008-5472.CAN-08-1982","article-title":"The \u03b2-catenin axis integrates multiple signals downstream from RET\/papillary thyroid carcinoma leading to cell proliferation","volume":"69","author":"Castellone","year":"2009","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.drup.2026.101437_bib25","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1200\/JCO.19.02727","article-title":"PD-1 blockade in anaplastic thyroid carcinoma","volume":"38","author":"Capdevila","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101437_bib26","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1172\/JCI46382","article-title":"Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation","volume":"121","author":"Chakravarty","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drup.2026.101437_bib27","first-page":"3801","article-title":"Increasing incidence of differentiated thyroid cancer in the United States, 1988\u20132005","volume":"115","author":"Chen","year":"2009","journal-title":"Cancer Interdiscip. Int. J. Am. Cancer Soc."},{"key":"10.1016\/j.drup.2026.101437_bib28","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/JCMA.0000000000000389","article-title":"Combination of peroxisome proliferator\u2013activated receptor gamma and retinoid X receptor agonists induces sodium\/iodide symporter expression and inhibits cell growth of human thyroid cancer cells","volume":"83","author":"Chen","year":"2020","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.drup.2026.101437_bib29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41419-020-2390-7","article-title":"MicroRNA-30a targets BECLIN-1 to inactivate autophagy and sensitizes gastrointestinal stromal tumor cells to imatinib","volume":"11","author":"Chen","year":"2020","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.drup.2026.101437_bib30","doi-asserted-by":"crossref","unstructured":"Chen, X., Li, Y., Xia, H., Chen, Y.H., 2023. Monocytes in Tumorigenesis and Tumor Immunotherapy.","DOI":"10.3390\/cells12131673"},{"key":"10.1016\/j.drup.2026.101437_bib31","doi-asserted-by":"crossref","first-page":"19843","DOI":"10.18632\/oncotarget.15773","article-title":"HER inhibitor promotes BRAF\/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E","volume":"8","author":"Cheng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2026.101437_bib32","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1210\/jc.2015-3433","article-title":"Robust thyroid gene expression and radioiodine uptake induced by simultaneous suppression of BRAF V600E and histone deacetylase in thyroid cancer cells","volume":"101","author":"Cheng","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drup.2026.101437_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103685","article-title":"Regulation of nasal airway homeostasis and inflammation in mice by SHP-1 and Th2\/Th1 signaling pathways","volume":"9","author":"Cho","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.drup.2026.101437_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/his.12002","article-title":"Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer","volume":"62","author":"Choi","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.drup.2026.101437_bib35","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180136","article-title":"Differentiated thyroid cancer theranostics: radioiodine and beyond","volume":"91","author":"Choudhury","year":"2018","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.drup.2026.101437_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061279","article-title":"Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors","volume":"18","author":"Chude","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2026.101437_bib37","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.4161\/auto.34398","article-title":"Autophagy regulator Beclin1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity","volume":"10","author":"Cicchini","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2026.101437_bib38","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/15548627.2017.1280223","article-title":"Tumor cell-intrinsic CD274\/PD-L1: A novel metabolic balancing act with clinical potential","volume":"13","author":"Clark","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2026.101437_bib39","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.drup.2026.101437_bib40","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/cdd.2014.183","article-title":"Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma","volume":"22","author":"Corazzari","year":"2015","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.drup.2026.101437_bib41","doi-asserted-by":"crossref","first-page":"T261","DOI":"10.1530\/ERC-17-0222","article-title":"Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way","volume":"24","author":"Cunha","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.drup.2026.101437_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1677\/JOE-09-0436","article-title":"MTOR downregulates iodide uptake in thyrocytes","volume":"206","author":"De Souza","year":"2010","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.drup.2026.101437_bib43","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.drup.2026.101437_bib44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nri3532","article-title":"Autophagy in infection, inflammation and immunity","volume":"13","author":"Deretic","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.drup.2026.101437_bib45","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.it.2014.09.006","article-title":"Tertiary lymphoid structures in cancer and beyond","volume":"35","author":"Dieu-Nosjean","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.drup.2026.101437_bib46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","article-title":"Mechanism and medical implications of mammalian autophagy","volume":"19","author":"Dikic","year":"2018","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.drup.2026.101437_bib47","first-page":"2697","article-title":"Rapid communication: Predominant intracellular overexpression of the Na+\/I\u2212 symporter (NIS) in a large sampling of thyroid cancer cases","volume":"86","author":"Doh\u00e1n","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drup.2026.101437_bib48","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4161\/auto.7.7.15491","article-title":"ULK1 inhibits mTORC1 signaling, promotes multisite Raptor phosphorylation and hinders substrate binding","volume":"7","author":"Dunlop","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2026.101437_bib49","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1210\/jc.2018-01478","article-title":"Vemurafenib Redifferentiation of BRAF Mutant, radioiodine-refractory Thyroid Cancers","volume":"104","author":"Dunn","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drup.2026.101437_bib50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molcel.2015.05.031","article-title":"Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates","volume":"59","author":"Egan","year":"2015","journal-title":"Mol. Cell."},{"key":"10.1016\/j.drup.2026.101437_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1099280","article-title":"Molecular features of aggressive thyroid cancer","volume":"12","author":"Elia","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2026.101437_bib52","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/01.rlu.0000233148.45744.44","article-title":"Enhanced radioiodine uptake in a patient with poorly differentiated papillary thyroid cancer after treatment with rosiglitazone","volume":"31","author":"Elias","year":"2006","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.drup.2026.101437_bib53","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrendo.2012.38","article-title":"Advances in the follow-up of differentiated or medullary thyroid cancer","volume":"8","author":"Elisei","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.drup.2026.101437_bib54","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbamcr.2008.07.014","article-title":"Autophagy: a lysosomal degradation pathway with a central role in health and disease","volume":"1793","author":"Eskelinen","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drup.2026.101437_bib55","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0854.2007.00677.x","article-title":"Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells","volume":"9","author":"Fader","year":"2008","journal-title":"Traffic"},{"key":"10.1016\/j.drup.2026.101437_bib56","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMra1501993","article-title":"Biologic and Clinical Perspectives on Thyroid Cancer","volume":"375","author":"Fagin","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2026.101437_bib57","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1530\/JME-19-0195","article-title":"Antagonistic effects of RAC1 and tumor-related RAC1b on NIS expression in thyroid","volume":"63","author":"Faria","year":"2019","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.drup.2026.101437_bib58","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/thy.2010.0008","article-title":"Sunitinib inhibits MEK\/ERK and SAPK\/JNK pathways and increases sodium\/iodide symporter expression in papillary thyroid cancer","volume":"20","author":"Fenton","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.drup.2026.101437_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20184413","article-title":"Immune and inflammatory cells in thyroid cancer microenvironment","volume":"20","author":"Ferrari","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2026.101437_bib60","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.3390\/cancers13143498","article-title":"Autophagy inhibition in BRAF-driven cancers","volume":"13","author":"Foth","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drup.2026.101437_bib61","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1677\/erc.1.00973","article-title":"Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture","volume":"12","author":"Fr\u00f6hlich","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.drup.2026.101437_bib62","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1111\/jcmm.15007","article-title":"Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAF(V600E) by synergistically decreasing global trimethylation of H3K27","volume":"24","author":"Fu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.drup.2026.101437_bib63","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.omto.2019.01.007","article-title":"MAPK Inhibitors Enhance HDAC Inhibitor-Induced Redifferentiation in Papillary Thyroid Cancer Cells Harboring BRAF (V600E): An In Vitro Study","volume":"12","author":"Fu","year":"2019","journal-title":"Mol. Ther. oncolytics"},{"key":"10.1016\/j.drup.2026.101437_bib64","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1038\/onc.2008.199","article-title":"Parkin as a tumor suppressor gene for hepatocellular carcinoma","volume":"27","author":"Fujiwara","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101437_bib65","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fendo.2019.00134","article-title":"The highly expressed FAM83F protein in papillary thyroid cancer exerts a pro-oncogenic role in thyroid follicular cells","volume":"10","author":"Fuziwara","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.drup.2026.101437_bib66","doi-asserted-by":"crossref","first-page":"856","DOI":"10.15252\/embj.201490784","article-title":"Autophagy in malignant transformation and cancer progression","volume":"34","author":"Galluzzi","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.drup.2026.101437_bib67","doi-asserted-by":"crossref","first-page":"E944","DOI":"10.1210\/jc.2013-1450","article-title":"Hypermethylation of a New Distal Sodium\/Iodide Symporter (NIS) enhancer (NDE) is associated with reduced NIS expression in thyroid tumors","volume":"99","author":"Galr\u00e3o","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drup.2026.101437_bib68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11912-026-01736-z","article-title":"Therapeutic Potential of Tyrosine Kinase Inhibitors in Advanced Thyroid Cancer","volume":"28","author":"Gangadaran","year":"2026","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.drup.2026.101437_bib69","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2015.12.008","article-title":"Inhibition of BRD4 suppresses tumor growth and enhances iodine uptake in thyroid cancer","volume":"469","author":"Gao","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drup.2026.101437_bib70","doi-asserted-by":"crossref","first-page":"10199","DOI":"10.1158\/0008-5472.CAN-04-4259","article-title":"Mutation of the PIK3CA gene in anaplastic thyroid cancer","volume":"65","author":"Garc\u00eda-Rost\u00e1n","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101437_bib71","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/PAT.0b013e3283486178","article-title":"BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis","volume":"43","author":"Gauchotte","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.drup.2026.101437_bib72","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1210\/jc.2003-030586","article-title":"Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas","volume":"88","author":"G\u00e9rard","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drup.2026.101437_bib73","series-title":"in: Seminars in Oncology","first-page":"S3","article-title":"Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth","author":"Gibbons","year":"2009"},{"key":"10.1016\/j.drup.2026.101437_bib74","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1089\/thy.2022.0704","article-title":"Challenges and strategies to combat resistance mechanisms in thyroid cancer therapeutics","volume":"33","author":"Gild","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/j.drup.2026.101437_bib75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2697","article-title":"Autophagy: cellular and molecular mechanisms","volume":"221","author":"Glick","year":"2010","journal-title":"J. Pathol."},{"key":"10.1016\/j.drup.2026.101437_bib76","doi-asserted-by":"crossref","unstructured":"Gotink, K.J., Broxterman, H.J., Labots, M., Haas, R.R.De, Dekker, H., 2011. Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance 7337\u20137346. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1667.","DOI":"10.1158\/1078-0432.CCR-11-1667"},{"key":"10.1016\/j.drup.2026.101437_bib77","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.18632\/oncotarget.6942","article-title":"BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells","volume":"7","author":"Goulielmaki","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2026.101437_bib78","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41416-018-0296-2","article-title":"Combinations of BRAF inhibitor and anti-PD-1\/PD-L1 antibody improve survival and tumor immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer","volume":"119","author":"Gunda","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2026.101437_bib79","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1101\/gad.2016311","article-title":"Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis","volume":"25","author":"Guo","year":"2011","journal-title":"Genes. Dev."},{"key":"10.1016\/j.drup.2026.101437_bib80","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1158\/1078-0432.CCR-18-2204","article-title":"Autophagy inhibition to augment mTOR inhibition: a phase I\/II trial of everolimus and hydroxychloroquine in patients with previously treated renal cell carcinoma","volume":"25","author":"Haas","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101437_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.drup.2026.101437_bib82","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJMoa1209288","article-title":"Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer","volume":"368","author":"Ho","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2026.101437_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.821855","article-title":"Targeting autophagy in thyroid cancer: EMT, apoptosis, and cancer stem cells","volume":"10","author":"Holm","year":"2022","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.drup.2026.101437_bib84","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fendo.2017.00260","article-title":"Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy","volume":"8","author":"Hong","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.drup.2026.101437_bib85","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1210\/jc.2009-1888","article-title":"Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways","volume":"95","author":"Hou","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drup.2026.101437_bib86","first-page":"30","article-title":"MicroRNA-mediated autophagy regulation in thyroid cancer drug resistance","volume":"8","author":"Huang","year":"2025","journal-title":"Cancer Drug. Resist."},{"key":"10.1016\/j.drup.2026.101437_bib87","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1089\/thy.2019.0143","article-title":"Mitogen-activated protein kinase pathway inhibition for redifferentiation of radioiodine refractory differentiated thyroid cancer: an evolving protocol","volume":"29","author":"Iravani","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.drup.2026.101437_bib88","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/cgt.2015.37","article-title":"Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation","volume":"22","author":"Jang","year":"2015","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.drup.2026.101437_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.624309","article-title":"SNAPIN Regulates Cell Cycle Progression to Promote Pancreatic \u03b2 Cell Growth","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.drup.2026.101437_bib90","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12444","article-title":"The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation","volume":"5","author":"Kabat","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.drup.2026.101437_bib91","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4161\/auto.7.1.13852","article-title":"Apoptosis to autophagy switch triggered by the MHC III-encoded receptor for advanced glycation endproducts (RAGE)","volume":"7","author":"Kang","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2026.101437_bib92","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/cdd.2010.191","article-title":"The Beclin1 network regulates autophagy and apoptosis","volume":"18","author":"Kang","year":"2011","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.drup.2026.101437_bib93","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1111\/febs.13540","article-title":"p62\/SQSTM1 functions as a signaling hub and an autophagy adaptor","volume":"282","author":"Katsuragi","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.drup.2026.101437_bib94","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.arabjc.2017.05.011","article-title":"Nanoparticles: Properties, applications and toxicities","volume":"12","author":"Khan","year":"2019","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.drup.2026.101437_bib95","first-page":"235","article-title":"Personalized treatment options for thyroid cancer: current perspectives","author":"Khatami","year":"2019","journal-title":"Pharmgenomics. Pers. Med."},{"issue":"1","key":"10.1016\/j.drup.2026.101437_bib96","article-title":"Radiation combined injury: DNA damage, apoptosis, and autophagy","volume":"2","author":"Kiang","year":"2010","journal-title":"Adapt. Med."},{"key":"10.1016\/j.drup.2026.101437_bib97","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4161\/15548627.2014.984276","article-title":"Insights into autophagosome maturation revealed by the structures of ATG5 with its interacting partners","volume":"11","author":"Kim","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2026.101437_bib98","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.humpath.2007.11.013","article-title":"Frameshift mutation of UVRAG, an autophagy-related gene, in gastric carcinomas with microsatellite instability","volume":"39","author":"Kim","year":"2008","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.drup.2026.101437_bib99","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1158\/0008-5472.CAN-08-4401","article-title":"Autophagy is activated by TGF-\u03b2 and potentiates TGF-\u03b2\u2013mediated growth inhibition in human hepatocellular carcinoma cells","volume":"69","author":"Kiyono","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101437_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)","volume":"17","author":"Klionsky","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2026.101437_bib101","doi-asserted-by":"crossref","DOI":"10.4161\/auto.28448","article-title":"Autophagosomes, phagosomes, autolysosomes, phagolysosomes, autophagolysosomes\u2026 wait, I\u2019m confused","author":"Klionsky","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2026.101437_bib102","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pharmthera.2012.06.007","article-title":"The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics","volume":"135","author":"Kogai","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drup.2026.101437_bib103","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1677\/JOE-08-0333","article-title":"Phosphoinositide-3-kinase inhibition induces sodium\/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells","volume":"199","author":"Kogai","year":"2008","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.drup.2026.101437_bib104","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1677\/erc.1.01143","article-title":"Enhancement of sodium\/iodide symporter expression in thyroid and breast cancer","volume":"13","author":"Kogai","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.drup.2026.101437_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.107259","article-title":"Dissolving microneedles as emerging tools in delivery of biological macromolecules: Current practices and future opportunities","author":"Kolekar","year":"2025","journal-title":"J. Drug. Deliv. Sci. Technol."},{"key":"10.1016\/j.drup.2026.101437_bib106","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1210\/endrev\/bnad001","article-title":"Recent advances in the role of autophagy in endocrine-dependent tumors","volume":"44","author":"Komarla","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.drup.2026.101437_bib107","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1158\/0008-5472.CAN-24-3785","article-title":"Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer","volume":"85","author":"Koshizuka","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101437_bib108","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jconrel.2022.12.042","article-title":"Co-crystal nanoarchitectonics as an emerging strategy in attenuating cancer: Fundamentals and applications","volume":"353","author":"Kumbhar","year":"2023","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.drup.2026.101437_bib109","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers[J]","volume":"126","author":"Landa","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.drup.2026.101437_bib110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-1-4939-3191-0_14","article-title":"Autophagy in Cancer Chemoprevention: Identification of Novel Autophagy Modulators with Anticancer Potential","volume":"1379","author":"Lao","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.drup.2026.101437_bib111","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.immuni.2009.12.006","article-title":"vivo requirement for ATG5 in antigen presentation by dendritic cells","volume":"32","author":"Lee","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.drup.2026.101437_bib112","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cub.2007.07.029","article-title":"ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration","volume":"17","author":"Lee","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/j.drup.2026.101437_bib113","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc.2017.53","article-title":"Targeting autophagy in cancer","volume":"17","author":"Levy","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2026.101437_bib114","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nnano.2011.153","article-title":"Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumor response","volume":"6","author":"Li","year":"2011","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.drup.2026.101437_bib115","article-title":"Advances in PD-1\/PD-L1 pathway inhibitors in the treatment of thyroid cancer: mechanisms and clinical therapeutic perspectives","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2026.101437_bib116","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1158\/0008-5472.CAN-12-0320","article-title":"Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression","volume":"72","author":"Liang","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101437_bib117","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.surg.2012.08.016","article-title":"Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancer","volume":"152","author":"Lin","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.drup.2026.101437_bib118","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.1217032","article-title":"GSK3-TIP60-ULK1 signaling pathway links growth factor deprivation to autophagy","volume":"336","author":"Lin","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.drup.2026.101437_bib119","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1096\/fj.201700061RR","article-title":"Interleukin 6 protects pancreatic \u03b2 cells from apoptosis by stimulation of autophagy","volume":"31","author":"Linnemann","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.drup.2026.101437_bib120","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1158\/1078-0432.CCR-06-1753","article-title":"Suppression of BRAF\/MEK\/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant","volume":"13","author":"Liu","year":"2007","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2026.101437_bib121","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3803\/EnM.2019.34.3.215","article-title":"Radioactive iodine-refractory differentiated thyroid cancer and redifferentiation therapy","volume":"34","author":"Liu","year":"2019","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.drup.2026.101437_bib122","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2011.08.037","article-title":"Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13","volume":"147","author":"Liu","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101437_bib123","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jamaoncol.2016.3288","article-title":"Mortality risk stratification by combining BRAF V600E and TERT promoter mutations in papillary thyroid cancer: genetic duet of BRAF and TERT promoter mutations in thyroid cancer mortality","volume":"3","author":"Liu","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.drup.2026.101437_bib124","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/ERC-15-0533","article-title":"TERT promoter mutations in thyroid cancer","volume":"23","author":"Liu","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.drup.2026.101437_bib125","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-13-0210","article-title":"Highly prevalent TERT promoter mutations in aggressive thyroid cancers","volume":"20","author":"Liu","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.drup.2026.101437_bib126","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11523-018-0565-2","article-title":"The role of autophagy in the resistance to BRAF inhibition in BRAF-mutated melanoma","volume":"13","author":"Liu","year":"2018","journal-title":"Target. Oncol."},{"key":"10.1016\/j.drup.2026.101437_bib127","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/eje.1.02123","article-title":"Bexarotene increases uptake of radioiodide in metastases of differentiated thyroid carcinoma","volume":"154","author":"Liu","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.drup.2026.101437_bib128","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2265.2006.02515.x","article-title":"Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies","volume":"64","author":"Liu","year":"2006","journal-title":"Clin. Endocrinol. (Oxf. )."},{"key":"10.1016\/j.drup.2026.101437_bib129","doi-asserted-by":"crossref","unstructured":"Loaiza-Bonilla, A., O\u2019Hara, M.H., Redlinger, M., Damjanov, N., Teitelbaum, U.R., Vasilevskaya, I., Rosen, M.A., Heitjan, D.F., Amaravadi, R.K., O\u2019Dwyer, P.J., 2015. Phase II trial of autophagy inhibition using hydroxychloroquine (HCQ) with FOLFOX\/bevacizumab in the first-line treatment of advanced colorectal cancer.","DOI":"10.1200\/jco.2015.33.15_suppl.3614"},{"key":"10.1016\/j.drup.2026.101437_bib130","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.celrep.2016.04.002","article-title":"Macroautophagy proteins control MHC I levels on dendritic cells and shape anti-viral CD8+ T cell responses","volume":"15","author":"Loi","year":"2016","journal-title":"Cell. Rep."},{"key":"10.1016\/j.drup.2026.101437_bib131","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrc3727","article-title":"Tumor-promoting tissue mechanics","volume":"14","author":"Lokody","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2026.101437_bib132","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/jc.2013-2574","article-title":"Synergistic Cooperation Between Sunitinib and Cisplatin Promotes Apoptotic Cell Death in Human Medullary Thyroid Cancer","volume":"99","author":"Lopergolo","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drup.2026.101437_bib133","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.biopha.2012.08.001","article-title":"Autophagy induction of reversine on human follicular thyroid cancer cells","volume":"66","author":"Lu","year":"2012","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.drup.2026.101437_bib134","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1172\/JCI70454","article-title":"Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma","volume":"124","author":"Ma","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drup.2026.101437_bib135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.immuni.2013.07.017","article-title":"Autophagy and cellular immune responses","volume":"39","author":"Ma","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.drup.2026.101437_bib136","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/jid.2010.26","article-title":"Induction of Autophagy and Inhibition of Melanoma Growth In Vitro and In Vivo by Hyperactivation of Oncogenic BRAF","volume":"130","author":"Maddodi","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.drup.2026.101437_bib137","doi-asserted-by":"crossref","unstructured":"Malhotra, J., Jabbour, S., Orlick, M., Riedlinger, G., Joshi, S., Guo, J.Y., White, E., Aisner, J., 2018. Modulation of autophagy with hydroxychloroquine in patients with advanced non-small cell lung cancer (NSCLC): A phase Ib study.","DOI":"10.1200\/JCO.2018.36.15_suppl.e21138"},{"key":"10.1016\/j.drup.2026.101437_bib138","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJMoa1109589","article-title":"Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer","volume":"366","author":"Mallick","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2026.101437_bib139","article-title":"Chloroquine and hydroxychloroquine for cancer therapy","volume":"1","author":"Manic","year":"2014","journal-title":"Mol. Cell. Oncol."},{"key":"10.1016\/j.drup.2026.101437_bib140","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.21873\/anticanres.13032","article-title":"Effect of Combined Epigenetic Treatments and Ectopic NIS Expression on Undifferentiated Thyroid Cancer Cells","volume":"38","author":"Massimino","year":"2018","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.drup.2026.101437_bib141","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.molcel.2014.07.019","article-title":"Functional role of autophagy-mediated proteome remodeling in cell survival signaling and innate immunity","volume":"55","author":"Mathew","year":"2014","journal-title":"Mol. Cell."},{"key":"10.1016\/j.drup.2026.101437_bib142","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4049\/jimmunol.1102041","article-title":"IFN-\u03b3 elicits macrophage autophagy via the p38 MAPK signaling pathway","volume":"189","author":"Matsuzawa","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.drup.2026.101437_bib143","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1073\/pnas.1118193109","article-title":"Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency","volume":"109","author":"McAfee","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drup.2026.101437_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.637826","article-title":"Immune landscape of thyroid cancers: new insights","volume":"11","author":"Menicali","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.drup.2026.101437_bib145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1677\/joe.0.1780205","article-title":"The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancer","volume":"178","author":"Mitsiades","year":"2003","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.drup.2026.101437_bib146","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1091\/mbc.e03-09-0704","article-title":"vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker","volume":"15","author":"Mizushima","year":"2004","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.drup.2026.101437_bib147","first-page":"289","article-title":"Reinduction of cell differentiation and 131I uptake in a poorly differentiated thyroid tumor in response to the reverse transcriptase (RT) inhibitor nevirapine","volume":"22","author":"Modoni","year":"2007","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.drup.2026.101437_bib148","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.sla.0000217685.85467.2d","article-title":"Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma","volume":"244","author":"Monchik","year":"2006","journal-title":"Ann. Surg."},{"issue":"7-8","key":"10.1016\/j.drup.2026.101437_bib149","doi-asserted-by":"crossref","first-page":"226","DOI":"10.18632\/genesandcancer.21","article-title":"PTEN deficiency and mutant p53 confer glucose-addiction to thyroid cancer cells: impact of glucose depletion on cell proliferation, cell survival, autophagy and cell migration","volume":"5","author":"Morani","year":"2014","journal-title":"Genes. & Cancer"},{"key":"10.1016\/j.drup.2026.101437_bib150","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19671","article-title":"Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors","volume":"6","author":"Mulcahy Levy","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.drup.2026.101437_bib151","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/ERC-17-0532","article-title":"Immune landscape of papillary thyroid cancer and immunotherapeutic implications","volume":"25","author":"Na","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.drup.2026.101437_bib152","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1172\/JCI89067","article-title":"Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine","volume":"126","author":"Nagarajah","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drup.2026.101437_bib153","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1089\/rej.2013.1500","article-title":"Gut-targeted immunonutrition boosting natural killer cell activity using Saccharomyces boulardii lysates in immuno-compromised healthy elderly subjects","volume":"17","author":"Naito","year":"2014","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.drup.2026.101437_bib154","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/me.2010-0102","article-title":"NF-\u03baB p65 subunit mediates lipopolysaccharide-induced Na+\/I\u2212 symporter gene expression by involving functional interaction with the paired domain transcription factor PAX8","volume":"24","author":"Nicola","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.drup.2026.101437_bib155","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1210\/jc.2002-021907","article-title":"RAS point mutations and PAX8-PPAR\u03b3 rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma","volume":"88","author":"Nikiforova","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drup.2026.101437_bib156","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/cen.13154","article-title":"A phase II trial of valproic acid in patients with advanced, radioiodine-resistant thyroid cancers of follicular cell origin","volume":"86","author":"Nilubol","year":"2017","journal-title":"Clin. Endocrinol. (Oxf. )"},{"key":"10.1016\/j.drup.2026.101437_bib157","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.7150\/thno.57689","article-title":"Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS","volume":"11","author":"Oh","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2026.101437_bib158","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/thy.2018.0626","article-title":"A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium\/Iodide Symporter Expression in Anaplastic Thyroid Cancer","volume":"30","author":"Oh","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.drup.2026.101437_bib159","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.18632\/oncotarget.24159","article-title":"Reverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor (K905-0266) excavated by high-throughput NIS (sodium iodide symporter) enhancer screening platform using dual reporter gene system","volume":"9","author":"Oh","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2026.101437_bib160","first-page":"972","article-title":"High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: Correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes","volume":"115","author":"Oler","year":"2009","journal-title":"Cancer Interdiscip. Int. J. Am. Cancer Soc."},{"key":"10.1016\/j.drup.2026.101437_bib161","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/eje.1.02158","article-title":"European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium","volume":"154","author":"Pacini","year":"2006","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.drup.2026.101437_bib162","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094086","article-title":"Role of genetic variants of autophagy genes in susceptibility for non-medullary thyroid cancer and patients outcome","volume":"9","author":"Plantinga","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.drup.2026.101437_bib163","doi-asserted-by":"crossref","first-page":"21235","DOI":"10.18632\/oncotarget.6908","article-title":"Autophagy-associated immune responses and cancer immunotherapy","volume":"7","author":"Pan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2026.101437_bib164","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2005.07.002","article-title":"Bcl-2 Antiapoptotic Proteins Inhibit Beclin1-Dependent Autophagy","volume":"122","author":"Pattingre","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101437_bib165","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.otohns.2007.07.030","article-title":"Increased iodine uptake in thyroid carcinoma after treatment with sodium butyrate and decitabine (5-Aza-dC)","volume":"137","author":"Provenzano","year":"2007","journal-title":"Otolaryngol. Neck Surg. Off. J. Am. Acad. Otolaryngol. Neck Surg."},{"key":"10.1016\/j.drup.2026.101437_bib166","first-page":"518","article-title":"Thyroglobulin as a tumor marker in differentiated thyroid cancer\u2013clinical considerations","volume":"57","author":"Prpi\u0107","year":"2018","journal-title":"Acta Clin. Croat."},{"key":"10.1016\/j.drup.2026.101437_bib167","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1089\/thy.2012.0359","article-title":"Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells","volume":"23","author":"Pugliese","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.drup.2026.101437_bib168","first-page":"397","article-title":"When autophagy meets cancer through p62\/SQSTM1","volume":"2","author":"Puissant","year":"2012","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.drup.2026.101437_bib169","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1210\/en.2005-0128","article-title":"Effects of histone acetylation on sodium iodide symporter promoter and expression of thyroid-specific transcription factors","volume":"146","author":"Puppin","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.drup.2026.101437_bib170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3858\/emm.2012.44.2.029","article-title":"Molecules and their functions in autophagy","volume":"44","author":"Pyo","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.drup.2026.101437_bib171","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1210\/en.2013-2011","article-title":"Adiponectin suppresses angiotensin II-induced inflammation and cardiac fibrosis through activation of macrophage autophagy","volume":"155","author":"Qi","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.drup.2026.101437_bib172","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.4161\/auto.29118","article-title":"Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma","volume":"10","author":"Rangwala","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2026.101437_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102945","article-title":"A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress","volume":"68","author":"Rawat","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.drup.2026.101437_bib174","doi-asserted-by":"crossref","first-page":"8317","DOI":"10.1158\/0008-5472.CAN-09-1248","article-title":"The BRAFV600E oncogene induces transforming growth factor \u03b2 secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer","volume":"69","author":"Riesco-Eizaguirre","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101437_bib175","first-page":"6105","article-title":"Overexpression and Overactivation of AkT in","volume":"1","author":"Ringel","year":"2001","journal-title":"Thyroid. Carcinoma"},{"key":"10.1016\/j.drup.2026.101437_bib176","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3413\/Nukmed-0474-12-01","article-title":"Pioglitazone therapy in progressive differentiated thyroid carcinoma","volume":"51","author":"Rosenbaum-Krumme","year":"2012","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.drup.2026.101437_bib177","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.4161\/auto.28984","article-title":"A phase I\/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme","volume":"10","author":"Rosenfeld","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2026.101437_bib178","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1158\/1078-0432.CCR-14-2915","article-title":"Redifferentiation of iodine-refractory BRAF V600E-mutant metastatic papillary thyroid cancer with dabrafenib","volume":"21","author":"Rothenberg","year":"2015","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2026.101437_bib179","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.957373","article-title":"Role of autophagy in tumor response to radiation: implications for improving radiotherapy","volume":"12","author":"Roy","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2026.101437_bib180","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12020-020-02417-y","article-title":"Involvement of HMGB1 in vemurafenib resistance in thyroid cancer cells harboring BRAF (V600E) mutation by regulating excessive autophagy","volume":"71","author":"Run","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.drup.2026.101437_bib181","doi-asserted-by":"crossref","first-page":"E829","DOI":"10.1210\/jc.2012-3933","article-title":"Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases","volume":"98","author":"Sabra","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drup.2026.101437_bib182","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jsps.2022.12.001","article-title":"A comprehensive review on pharmacological applications and drug-induced toxicity of valproic acid","volume":"31","author":"Safdar","year":"2023","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.drup.2026.101437_bib183","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-cancerbio-041816-122338","article-title":"The Role of Autophagy in Cancer","volume":"1","author":"Santana-Codina","year":"2017","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.drup.2026.101437_bib184","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","article-title":"The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.drup.2026.101437_bib185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1593\/neo.121228","article-title":"Interleukin-1\u03b2 promotes ovarian tumorigenesis through a p53\/NF-\u03baB-mediated inflammatory response in stromal fibroblasts","volume":"15","author":"Schauer","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.drup.2026.101437_bib186","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1108586","article-title":"Strategies of radioiodine ablation in patients with low-risk thyroid cancer","volume":"366","author":"Schlumberger","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.drup.2026.101437_bib187","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.drup.2026.101437_bib188","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/jir.2013.0128","article-title":"New function of type I IFN: induction of autophagy","volume":"34","author":"Schmeisser","year":"2014","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.drup.2026.101437_bib189","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12957-016-0946-x","article-title":"Prognostic relevance of autophagy-related markers LC3, p62\/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status","volume":"14","author":"Schmitz","year":"2016","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.drup.2026.101437_bib190","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","article-title":"Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling","volume":"38","author":"Sena","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.drup.2026.101437_bib191","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fonc.2020.00404","article-title":"Nevirapine increases sodium\/iodide symporter-mediated radioiodide uptake by activation of TSHR\/cAMP\/CREB\/PAX8 signaling pathway in dedifferentiated thyroid cancer","volume":"10","author":"Shang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2026.101437_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101013","article-title":"Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance","volume":"72","author":"Shen","year":"2024","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.drup.2026.101437_bib193","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1038\/onc.2011.168","article-title":"Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study","volume":"30","author":"Shen","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101437_bib194","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2012.0393","article-title":"Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma","volume":"23","author":"Sherman","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.drup.2026.101437_bib195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s12967-023-04265-6","article-title":"The new insights into autophagy in thyroid cancer progression","volume":"21","author":"Shi","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.drup.2026.101437_bib196","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1055\/s-0029-1211692","article-title":"Redifferentiation therapy of differentiated thyroid carcinoma with retinoic acid: basics and first clinical results","volume":"104","author":"Simon","year":"1996","journal-title":"Exp. Clin. Endocrinol. Diabetes Off. J. Ger. Soc. Endocrinol. Ger. Diabetes Assoc."},{"key":"10.1016\/j.drup.2026.101437_bib197","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.2967\/jnumed.115.160366","article-title":"Inverse Agonist of Estrogen-Related Receptor \u03b3 Enhances Sodium Iodide Symporter Function Through Mitogen-Activated Protein Kinase signaling in Anaplastic Thyroid Cancer Cells","volume":"56","author":"Singh","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.drup.2026.101437_bib198","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1038\/sj.onc.1206706","article-title":"BRAF mutations and RET\/PTC rearrangements are alternative events in the etiopathogenesis of PTC","volume":"22","author":"Soares","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101437_bib199","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1517\/14728222.2011.594044","article-title":"The mTOR protein as a target in thyroid cancer","volume":"15","author":"Souza","year":"2011","journal-title":"Expert. Opin. Ther. Targets"},{"key":"10.1016\/j.drup.2026.101437_bib200","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1210\/jc.2005-0523","article-title":"Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis","volume":"90","author":"Stratford","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drup.2026.101437_bib201","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.2017.73.6785","article-title":"Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer","volume":"36","author":"Subbiah","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101437_bib202","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1038\/onc.2010.261","article-title":"HMGB1 release and redox regulates autophagy and apoptosis in cancer cells","volume":"29","author":"Tang","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101437_bib203","first-page":"716","article-title":"Dissection of the RET\/\u03b2-catenin interaction in the TPC1 thyroid cancer cell line","volume":"1","author":"Tartari","year":"2011","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.drup.2026.101437_bib204","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1158\/1535-7163.MCT-16-0460","article-title":"Digitalis-like Compounds Facilitate Non-Medullary Thyroid Cancer Redifferentiation through Intracellular Ca2+, FOS, and Autophagy-Dependent Pathways","volume":"16","author":"Tesselaar","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2026.101437_bib205","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1074\/jbc.R117.810739","article-title":"Autophagy and disease","volume":"293","author":"Thorburn","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101437_bib206","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70464","article-title":"Dual Roles of Autophagy in Radiation-Induced Brain Injury: Mechanistic Insights and Therapeutic Implications","volume":"31","author":"Tian","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.drup.2026.101437_bib207","article-title":"Antitumor Activity of Lenvatinib ( E7080): An Angiogenesis Inhibitor That Targets Multiple Receptor Tyrosine Kinases in Preclinical Human Thyroid Cancer Models","volume":"2014","author":"Tohyama","year":"2014"},{"key":"10.1016\/j.drup.2026.101437_bib208","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0889-8529(05)70194-8","article-title":"Serum thyroglobulin measurement: utility in clinical practice","volume":"30","author":"Torr\u00e9ns","year":"2001","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"10.1016\/j.drup.2026.101437_bib209","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061405","article-title":"PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications","volume":"20","author":"Ulisse","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2026.101437_bib210","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.ejca.2012.01.029","article-title":"Carcinoma of endocrine organs: results of the RARECARE project","volume":"48","author":"Van Der Zwan","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.drup.2026.101437_bib211","first-page":"2449","article-title":"Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+\/I-symporter gene methylation status","volume":"84","author":"Venkataraman","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drup.2026.101437_bib212","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1210\/jc.2016-1999","article-title":"Targeting Autophagy Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib","volume":"102","author":"Wang","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drup.2026.101437_bib213","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13046-019-1148-5","article-title":"Autophagy inhibition enhances PD-L1 expression in gastric cancer","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101437_bib214","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3892\/ol.2014.2487","article-title":"BRAF\u2011activated long non\u2011coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma","volume":"8","author":"Wang","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.drup.2026.101437_bib215","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/030089161109700420","article-title":"Expression and correlation of sodium\/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma","volume":"97","author":"Wang","year":"2011","journal-title":"Tumor J."},{"key":"10.1016\/j.drup.2026.101437_bib216","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3835(03)00392-6","article-title":"Low expression of sodium iodide symporter identifies aggressive thyroid tumors","volume":"200","author":"Ward","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2026.101437_bib217","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70357","article-title":"Programmed Cell Death in Cancer","volume":"6","author":"Wei","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.drup.2026.101437_bib218","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1038\/emboj.2010.74","article-title":"LC3 and GATE-16\/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis","volume":"29","author":"Weidberg","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.drup.2026.101437_bib219","doi-asserted-by":"crossref","unstructured":"Wen, L., Ding, K., Wang, Z., Ding, C., Lei, S., Liu, J., Yin, C., Hu, P., Ding, J., Chen, W., Zhang, X., 2018. SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression 2001, 4680\u20134691. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3896.","DOI":"10.1158\/0008-5472.CAN-17-3896"},{"key":"10.1016\/j.drup.2026.101437_bib220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022842","article-title":"Human tumor immune evasion via TGF-\u03b2 blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumor activity","volume":"6","author":"Wilson","year":"2011","journal-title":"PLoS. One"},{"key":"10.1016\/j.drup.2026.101437_bib221","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101437_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.102610","article-title":"The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma","volume":"51","author":"Xia","year":"2020","journal-title":"eBioMedicine"},{"key":"10.1016\/j.drup.2026.101437_bib223","doi-asserted-by":"crossref","unstructured":"Xiang, Q., Chen, W., Ren, M., Wang, J., Zhang, H., Deng, D.Y.B., 2014. Cabozantinib Suppresses Tumor Growth and Metastasis in Hepatocellular Carcinoma by a Dual Blockade of VEGFR2 and MET 2959\u20132970. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-2620.","DOI":"10.1158\/1078-0432.CCR-13-2620"},{"key":"10.1016\/j.drup.2026.101437_bib224","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc3431","article-title":"Molecular pathogenesis and mechanisms of thyroid cancer","volume":"13","author":"Xing","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2026.101437_bib225","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1089\/thy.2010.1646","article-title":"Genetic alterations in the phosphatidylinositol-3 kinase\/AkT pathway in thyroid cancer","volume":"20","author":"Xing","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.drup.2026.101437_bib226","article-title":"SIRT1\/PGC-1\u03b1\/PPAR-\u03b3 correlate with hypoxia-induced chemoresistance in non-small cell lung cancer","volume":"11","author":"Xu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2026.101437_bib227","first-page":"1457","article-title":"Autophagy regulates anti-angiogenic property of lenvatinib in thyroid cancer","volume":"13","author":"Xue","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.drup.2026.101437_bib228","first-page":"1","article-title":"Active Surveillance for Papillary Thyroid Microcarcinoma: Challenges and Prospects","volume":"9","author":"Xue","year":"2018"},{"key":"10.1016\/j.drup.2026.101437_bib229","first-page":"2298","article-title":"Cabozantinib ( XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth","volume":"10","author":"Yakes","year":"2011"},{"key":"10.1016\/j.drup.2026.101437_bib230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41571-022-00601-9","article-title":"Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics","volume":"19","author":"Yamaguchi","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101437_bib231","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","article-title":"Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I","volume":"581","author":"Yamamoto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101437_bib232","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nri.2017.9","article-title":"Dying cells actively regulate adaptive immune responses","volume":"17","author":"Yatim","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.drup.2026.101437_bib233","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.7150\/jca.50292","article-title":"Lenvatinib induces anticancer activity in gallbladder cancer by targeting AkT","volume":"12","author":"Ye","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.drup.2026.101437_bib234","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091865","article-title":"Monitoring and Measuring Autophagy","volume":"18","author":"Yoshii","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2026.101437_bib235","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s13277-013-0648-8","article-title":"Beclin1 expression is an independent prognostic factor for gastric carcinomas","volume":"34","author":"Yu","year":"2013","journal-title":"Tumor Biol."},{"key":"10.1016\/j.drup.2026.101437_bib236","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1042\/EBC20170021","article-title":"The mammalian ULK1 complex and autophagy initiation","volume":"61","author":"Zachari","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.drup.2026.101437_bib237","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13044-018-0057-6","article-title":"Synergistic inhibition of MEK\/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium\/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells","volume":"11","author":"Zhang","year":"2018","journal-title":"Thyroid. Res."},{"key":"10.1016\/j.drup.2026.101437_bib238","first-page":"670","article-title":"Discovery of a Novel Selective PAK1\/HDAC6\/HDAC10 Inhibitor ZMF-25 that Induces Mitochondrial Metabolic Breakdown and Autophagy-Related Cell Death in Triple-Negative Breast Cancer","volume":"8","author":"Zhang","year":"2025","journal-title":"Res. (Wash. D. C. )"},{"key":"10.1016\/j.drup.2026.101437_bib239","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s13277-013-1261-6","article-title":"Aberrant Beclin1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma","volume":"35","author":"Zhao","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.drup.2026.101437_bib240","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cell.2016.05.051","article-title":"Autophagy, inflammation, and immunity: a troika governing cancer and its treatment","volume":"166","author":"Zhong","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101437_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2025.107513","article-title":"Turning tumor microenvironmental foes to friends: A new opportunity for thyroid cancer therapy and redifferentiation","volume":"168","author":"Zhu","year":"2025","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.drup.2026.101437_bib242","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumor environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.drup.2026.101437_bib243","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.3390\/cimb46030142","article-title":"Autophagy-Dependent Secretion: Crosstalk between Autophagy and Exosome Biogenesis","volume":"46","author":"Zubkova","year":"2024","journal-title":"Curr. Issues Mol. Biol."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:50:34Z","timestamp":1784836234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":243,"alternative-id":["S1368764626000889"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101437","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autophagy in thyroid cancer: Immune suppression and drug resistance","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101437"}}